Search Results 381-390 of 16790 for alt

  1. Veliparib with or without Carboplatin in Treating Patients with Stage III or Stage IV Breast Cancer - Mayo Clinic

    Aspartate aminotransferase (AST) serum glutamic oxaloacetic transaminase (SGOT) and alanine aminotransferase (ALT) serum glutamate pyruvate transaminase ...

  2. IL-2 plus FOLFOX and Nivolumab for Treatment of Peritoneal Metastases - Mayo Clinic

    Alanine aminotransferase (ALT) AND aspartate transaminase (AST) ≤ 1.5 x ULN;; PT/INR/aPTT ≤ 1.5 x ULN; OR if patient is receiving anticoagulant therapy ...

  3. A Study of AFP464 for Treating Patients with Solid Tumors that are Metastatic or Resistant to Treatment, and Cannot Be Removed By Surgery - Mayo Clinic

    Total bilirubin ≤ upper limits of normal (ULN); Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ≤ 2.5 x ULN; Creatinine ≤ 1.25 x ULN. If ...

  4. Phase 2 Study to Evaluate the Oral Combination of Ixazomib (MLN9708) With Cyclophosphamide and Dexamethasone in Patients With Newly Diagnosed or Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

    Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ 3 x ULN. Calculated creatinine clearance (CrCL) ≥ 30 mL/min. Eastern Cooperative ...

  5. A Study To Assess The Safety And Tolerability Of CFT7455 In Relapsed/Refractory Non-Hodgkin's Lymphoma Or Multiple Myeloma - Mayo Clinic

    - ALT and AST ≤3.0 x upper limit of normal (ULN); except for subjects who have tumor infiltration of the liver, where ALT or AST ≤5 x ULN. - Total ...

  6. A Study of X4P-001 in Patients with Advanced Renal Cell Carcinoma - Mayo Clinic

    Serum alanine transaminase (ALT) >2.5x ULN;; Total bilirubin >1.5x ULN (unless due to Gilbert's Syndrome). Has received other anti-cancer therapy within the ...

  7. ROR1771: A Prospective Observational Study of Proton Stereotactic Body Radiation Therapy and Immunotherapy for Recurrent/Progressive Locoregional or Metastatic Head and Neck Cancer - Mayo Clinic

    AST/ALT ≤ 3 x ULN; Total bilirubin <1.5 x ULN (except subjects with Gilbert Syndrome who can have total bilirubin <3.0 mg/deciliter). Women of childbearing ...

  8. Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery - Mayo Clinic

    AST/SGOT and ALT/SGPT ≤ 2.5 X ULN; Negative serum pregnancy test and using medically acceptable form of contraception if of child bearing potential; LVEF ...

  9. A Study of Using Bortezomib and Combination Chemotherapy in Treating Children with Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma - Mayo Clinic

    ... [ALT]) < 3 x ULN for age, unless elevation due to leukemia infiltration; Shortening fraction of ≥ 27% by echocardiogram, or; Ejection fraction of ≥ 50% by ...

  10. A Trial of the Effectiveness and Safety of CVL-865 to Treat Focal Onset Seizures - Mayo Clinic

    Participation eligibility · AST or ALT ≥ 2 x ULN; · Total bilirubin ≥ 1.5 x ULN. · Females: Hemoglobin < 11 g/dL | Males: hemoglobin < 12 g/dL; · White blood cell ...